← Leaderboards
Jennifer Jean Trowbridge
Jackson Laboratory
$8,409,794
Attributed
$10,092,127
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,092,127 · 8
By mechanism
R01$6,018,078 · 2
U01$2,907,195 · 1
R56$593,103 · 3
R21$426,426 · 1
P30$147,325 · 1
Top collaborators
- Ross L Levine7 shared
- Sheng Li1 shared
- Hideyuki Oguro1 shared
Most similar at Jackson Laboratory
Same institution · by research overlap
- Sheng Li$6,545,752
- George A Kuchel$21,469,430
- Gary A Churchill$29,555,134
- David E Harrison$38,121,003
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoHematopoietic Stem CellsComplexAgingHematopoieticAge RelatedBloodPublic HealthTissuesMutationBiologicalIncidencePreventMolecularHematopoiesisSignal TransductionResponseHematopoietic NeoplasmsAgedCellsMiddle AgeMutantBone MarrowDnmt3a
Grant awards (27)
Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-Extrinsic and Cell-Intrinsic Alterations at Middle Age$615,355
R01 · FY2025 · DK · contact PI
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation$509,734
U01 · FY2025 · AG · contact PI
Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-Extrinsic and Cell-Intrinsic Alterations at Middle Age$615,355
R01 · FY2024 · DK · contact PI
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation$523,054
U01 · FY2024 · AG · contact PI
Discovery of Aging-Associated Mechanisms Causing Expansion and Progression of Clonal Hematopoiesis of Indeterminant Potential (CHIP)$489,247
R01 · FY2024 · AG · contact PI
Inflammatory Signaling in DNMT3A-Mutated Human Hematopoietic Stem Cells$197,925
U01 · FY2024 · AG · contact PI
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation$104,865
U01 · FY2024 · AG · contact PI
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation$515,538
U01 · FY2023 · AG · contact PI
Discovery of Aging-Associated Mechanisms Causing Expansion and Progression of Clonal Hematopoiesis of Indeterminant Potential (CHIP)$472,769
R01 · FY2023 · AG · contact PI
Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-Extrinsic and Cell-Intrinsic Alterations at Middle Age$100,000
R56 · FY2023 · DK · contact PI
Research Program$49,107
P30 · FY2023 · CA · contact PI
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation$518,079
U01 · FY2022 · AG · contact PI
Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-extrinsic and Cell-intrinsic Alterations at Middle Age$478,279
R01 · FY2022 · DK · contact PI
Discovery of Aging-Associated Mechanisms Causing Expansion and Progression of Clonal Hematopoiesis of Indeterminant Potential (CHIP)$470,678
R01 · FY2022 · AG · contact PI
3D Genome Reorganization and Epigenome Dynamics of Clonal Hematopoiesis$343,103
R56 · FY2022 · AG
Research Program$49,109
P30 · FY2022 · CA · contact PI
Assessing the Interplay Between Inflammatory Signaling and Epigenetic Dysregulation in Age-associated Clonal Hematopoiesis and Leukemia Initiation$538,000
U01 · FY2021 · AG · contact PI
Discovery of Aging-Associated Mechanisms Causing Expansion and Progression of Clonal Hematopoiesis of Indeterminant Potential (CHIP)$477,927
R01 · FY2021 · AG · contact PI
Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-extrinsic and Cell-intrinsic Alterations at Middle Age$477,513
R01 · FY2021 · DK · contact PI
Research Program$49,109
P30 · FY2021 · CA · contact PI
Discovery of Aging-Associated Mechanisms Causing Expansion and Progression of Clonal Hematopoiesis of Indeterminant Potential (CHIP)$492,639
R01 · FY2020 · AG · contact PI
Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-extrinsic and Cell-intrinsic Alterations at Middle Age$477,513
R01 · FY2020 · DK · contact PI
Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-extrinsic and Cell-intrinsic Alterations at Middle Age$477,513
R01 · FY2019 · DK · contact PI
Developing Effective Approaches to Extend Hematopoietic Healthspan by Targeting Cell-extrinsic and Cell-intrinsic Alterations at Middle Age$473,290
R01 · FY2018 · DK · contact PI
Aging-induced Alterations in the Microenvironment as Drivers of Myeloid Lineage Skewing$150,000
R56 · FY2017 · DK · contact PI
(PQB5) Epigenetic Drivers of Hematopoietic Stem Cell Transformation$195,963
R21 · FY2015 · CA · contact PI
(PQB5) Epigenetic Drivers of Hematopoietic Stem Cell Transformation$230,463
R21 · FY2014 · CA · contact PI